Last updated on April 2019

A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable

Brief description of study

The purpose of this study is to determine the efficacy and safety of baricitinib in combination with topical corticosteroids in participants with moderate to severe atopic dermatitis who have experienced failure to cyclosporine or are intolerant to, or have contraindication to cyclosporine.

Clinical Study Identifier: NCT03428100

Find a site near you

Start Over

Iidabashi Clinic

Chiyoda-ku, Japan
  Connect »

Nihonbashi Sakura Clinic

Chuo-ku, Japan
  Connect »

Sumire Dermatology Clinic

Edogawa-ku, Japan
  Connect »

Yanagihara dermatology clinic

Ainokawa, Ichikawa-shi, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.